White, B., Katzka, D., Lynch,. KL. Evolving Therapeutic Options in Eosinophilic Esophagitis , Expert Review of Gastroenterology & Hepatology: 2027
Dellon ES, Carlson DA, Greuter T, Collins MH, Lankarani A, Talreja N, Ravi K, Simões Neto J, Afif W, Gonsalves NP, Lynch KL, Zaghloul S, Cunoosamy D, Durrani SR, Zhang M, Raphael BP, Angello JT, Radwan A, Almansa C, Biedermann L Dupilumab Improves Esophageal Distensibility in Adults With Eosinophilic Esophagitis: 24-Week Results From the REMODEL Trial , 8th CURED Research Conference and Patient Education Program. Cincinnati, OH.: 2026
Dellon, E. S.; Carlson, D. A.; Greuter, T.; Collins, M. H.; Lankarani, A.; Talreja, N.; Ravi, K.; Simões Neto, J.; Afif, W.; Gonsalves, N. P.; Lynch, K. L.; Hodges, S.; Zaghloul, S.; Cunoosamy, D.; Durrani, S. R.; Zhang, M.; Raphael, B. P.; Angello, J. T.; Levy, S. D.; Almansa, C.; Biedermann, L. Dupilumab Improves Esophageal Distensibility and Endoscopic Features in Adults With Eosinophilic Esophagitis: 24-Week Results From the Phase 4 Long-Term REMODEL Trial , Gastroenterology and Hepatology Advanced Practice Providers 2026 Annual Conference. Chula Vista, CA.: 2026
Bellam, K., Lee, B., Lynch, KL. Dupixent Dosage Decision: Exploring the Histologic Trend for a Change from Weekly to Every Other Week in Eosinophilic Esophagitis , The World Organization for Specialized Studies on Diseases of the Esophagus 17th World Conference. Versailles, France.: 2026
Bellam, K., Lee, B., Lynch, KL. Eosinophilic Esophagitis Response Rates in Real Life. , The World Organization for Specialized Studies on Diseases of the Esophagus 17th World Conference. Versailles, France.: 2026
Bellam, K., Lee, Briton., Muir, A., Lynch, KL. Hard to Swallow: Treatment Adherence Challenges in Eosinophilic Esophagitis , The World Organization for Specialized Studies on Diseases of the Esophagus 17th World Conference. Versailles, France.: 2026
Dash A, Starling AS, Shaffer S, Muir A, Lynch KL. Assessing the performance of a new diagnostic criterion for diagnosing esophageal lichen planus , Diseases of the Esophagus: 2026
Jensen, E.T., Katz, I., Abonia, J.P., Bailey, D.D., Chang, J.W., Chehade, M., Davis, C., Dellon, E.S., Furuta, G., Gupta, S.K., Menard-Katcher, C.D., Khoury, P., Kline, D., Klion, A., Kodroff, E., Lynch, K.L., Mehta, P., Mukkada, V.A., Nistel, M., Pesek, R., Rothenberg, M.E., Shoda, T., Starling, A.L.S., Strobel, M.J., Wright, B.L., Muir, A.B. Disproportionate Management of Esophageal Food Impactions: A Multi-Institutional Study , Digestive Diseases Week. Chicago, IL.: 2026
Thiele, K., Lee, B., Bellam, K., Rosoff-Verbit, Z., Sodagum, L., Davis, T., Spergel, J., Buckey, T., Muir, A., Lynch, KL. When Relief Hurts: Exploring the Adverse Effect Profile of Dupilumab in Children and Adults With Eosinophilic Esophagitis. , Digestive Diseases Week. Chicago, IL.: 2026
Dellon, E. S.; Carlson, D. A.; Greuter, T.; Collins, M. H.; Lankarani, A.; Talreja, N.; Ravi, K.; Simões Neto, J.; Afif, W.; Gonsalves, N. P.; Lynch, K. L.; Zaghloul, S.; Cunoosamy, D.; Durrani, S. R.; Zhang, M.; Raphael, B. P.; Angello, J. T.; Radwan, A.; Almansa, C.; Biedermann, L. Dupilumab Improves Esophageal Distensibility in Adults With Eosinophilic Esophagitis: 24-Week Results From the Randomized, Placebo-Controlled Remodeling With Dupilumab in Eosinophilic Esophagitis Long Term (REMODEL) Trial , Digestive Diseases Week. Chicago, IL.: 2026
